As antimicrobial medicines become less effective, the risk for people living with cancer increases. There is a pressing need for new approaches to address AMR, from better infection prevention and control to research and development for new medicines and diagnostics.

“So it goes.” 

This was how I finished a text message to a friend after informing her of my diagnosis with high-risk and advanced Mantle Cell Lymphoma, a cancer that is around three times more common in men than women, is typically widespread at diagnosis, and has a rare incidence rate of one case per 200,000 people worldwide.